Activity value 76International Buyer&Supplier,Last transaction date:
2026-07-31
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for qm pharma quality medicine s.a.c. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 107 transactions, with a transaction quantity of 211196.3 and a transaction weight of 74306.3.
YearTransactionsQuantityWeight
2025220711785.66103460.57
2026107211196.374306.3
Bill of lading data
<
1/15
>
Trade date
2026/07/31
B/L No.
126017
Suppliers
laboratorios cinfa
Buyers
qm pharma quality medicine s.a.c.
Product description
VIRIGOR 20MG COMPRIMIDO RECUBIERTO CON PELICULA, VIRIGOR, S/M VIRIGOR 20MG COMPRIMIDO RECUBIERTO CON PELICULA MEDICAMENTOS PARA USO HUMANO / LOTE NO: BA2047 MFG: 04/26, EXP: 04/29 VIRIGOR 20 4C PER EMPAQUE: CAJA X 4, R.D.N°8994-2023-DIGEMID/DPF/EMNDYO/MINSA,CREDITO A 120 DIAS FECHA DE FA
Expand
Product description
PANTOPRAZOL 40MG, S/M, S/M LOTE: 2606076 - F. PROD.: 06/2026 - F. VCTO.: 05/2029 MEDICAMENTOS PARA USO HUMANO PANTOPRAZOL 40MG TABLETA DE LIBERACION RETARDADA EMPAQUE: CAJA X 90 CAPSULAS DE LIBERACION RETARDADA // R.D. NO 003787-2026-DIGEMID/DPF/EMN
Expand
Product description
PANTOPRANEX 40MG, PANTOPRANEX, S/M LOTE: 2606078 - F. PROD.: 06/2026 - F. VCTO.: 05/2029 MEDICAMENTOS PARA USO HUMANO PANTOPRANEX 40MG TABLETA DE LIBERACION RETARDADA. EMPAQUE: CAJA X 30 CAPSULAS DE LIBERACION RETARDADA // R.D. NO 003788-2026-DIGEMID/DPF/EMN
Expand
Product description
SPASMONIUM 40MG, SPASMONIUM, S/M LOTE: TL507CT26001 - F. PROD.: 04/2026 - F. VCTO.: 03/2029 MEDICAMENTOS PARA USO HUMANO SPASMONIUM (BROMURO DE OTILONIO TABLETAS DE 40MG) EMPAQUE: CAJA X 10 TABLETAS // R.D. NO 020085-2025-DIGEMID/DPF/EMNDYO/MINSA,PAGO A CREDITO
Expand
Trade date
2026/07/06
B/L No.
322885
Suppliers
livespo pharma co.ltd.
Buyers
qm pharma quality medicine s.a.c.
Product description
PREGABALINA 25MG, S/M, S/M LOTE: C26031 - F. PROD.: 05/2026 - F. VCTO.: 04/2029 MEDICAMENTOS PARA USO HUMANO PREGABALINA 25MG CAPSULAS CAJA X 30 CAPSULAS EMPAQUE: CAJA POR 30 CAPSULAS // R.D. NO 11182-2023-DIGEMID/DPF/EMNDYO/MINSA,PAGO A CREDIT
Expand
qm pharma quality medicine s.a.c. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as voltaren,fer-in-sol,bronax.
According to the 52wmb.com global trade database, as of 2026-07-31, the company has completed 1209 international trades,
with its main trading regions covering india,other,vietnam etc.
The core products include HS3004902900,HS30049099,HS30049069 etc,
often transported via lima,port callao, port marítima del callao etc,
and its main trading partners are globela pharma pvt ltd.,higlance laboratories pvt ltd.,coral laboratories ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on qm pharma quality medicine s.a.c. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.